Clomipramine versus sertraline in the treatment of obsessive compulsive disorder

Klinik Psikofarmakoloji Bulteni

Volumn 9, Issue 3, 1999, Pages 133-138

  Aşkin, Rüstem ^a   Turan, Metin ^a   Çilli, Ali Savaş ^a   Kaya, Nazmiye ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Clomipramine; Obsessive compulsive disorder; Sertraline; Treatment

Indexed keywords

EID: 53149110466     PISSN: 10177833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L. Clomipramine treatment of obsessive-compulsive disorder. A controlled clinical trial. Arch Gen Psychiatry 1980; 37:1281-1285.
2. Zohar J, Insel TR. Obsessive-compulsive disorder psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 1987; 22:667-687.
3. McTavish D, Benfield P. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive-compulsive disorder. Drugs 1990; 39:136-153.
4. Jermain DM, Crismon ML. Pharmacotherapy of obsessive-compulsive disorder. Pharmacotherapy 1990; 10:175-198.
5. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 1995; 52:53-60.
6. Greist JH. An integrated approach to treatment of obsessive compulsive disorder. J Clin Psychiatry 1992; 53:38-41.
7. Tollefson GD; Rampey AH Jr; Potvin JH; Jenike MA; Rush AJ; Kominguez RA et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994; 51:559-567.
8. Bisserbe JC, Lane RM, Flament MF. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder. Eur Psychiatry 1997; 12:82-93.
9. DeVeaugh-Geiss J, Landau P, Katz R. Treatment of obsessive-compulsive disorder with clomipramine. Psychiatric Annals 1989; 19:97-101.
10. Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative- studies. J Clin Psychiatry 1997; 58:18-22.
11. Montgomery SA. Long-term management of obsessive-compulsive disorder. Int Clin Psychopharmacol 1996; 11:23-29.
12. Chouinard G. Sertraline in the treatment of obsessive compulsive disorder: two double blind, placebo-controlled studies. Int Clin Psychopharmacol 1992; 7:37-41.
13. Dominguez RA. Serotonergic antidepressants and their efficacy in obsessive disorder. J Clin Psychiatry 1992; 53:56-59.
14. Pigott TA, Grady TA, Rubenstein CS. Obsessive-compulsive disorder and trichotillomania. In: Dunner DI, editor. Current Psychiatric Therapy. Philadelphia, W. B. Saunders Company, 1993; 282-287.
15. Johnson MR, Lydiard RB. Future trends in the psychophar-macology of anxiety disorders. In Dunner DL, editors. Current Psychiatric Therapy. Philadelphia, W.B. Saunders Com-pany, 1993:539-544.
16. Tollefson GD. Selective reuptake inhibitors. In Schatzberg AF, Nemeroff CB, editors. Textbook of Psycho-pharmacology, Washington DC, Psychiatric Press Inc, 1995:161-182.
17. Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry 1995; 166:424-443.
18. Flament MF. Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent. Encephale 1993; 19:75-81.
19. Jackson CW, Morton WA, Lydiard RB. Pharmacologic management of obsessive-compulsive disorder. South Med J 1994; 87:310-321.
20. DeVeaugh Geiss J. Pharmacologic therapy of obsessive compulsive disorder. Adv Pharmacol 1994; 30:35-52.
21. Pary R, Lippmann S, Tobias CR. Obsessive-compulsive disorder. How to free patients from intrusive thoughts and rituals. Postgrad Med 1994; 96:119-125.